Dr. Reddy's Laboratories500124Pharmaceuticals
DRL saw fresh long addition and was double-upgraded from sell to buy by Citi
Heard on Live TV News Channel between 07:37:09 - 07:38:24 IST.
- DRL saw fresh addition on the long side
- Citi double upgraded the stock from sell to buy
Also from Dr. Reddy's Laboratories
Citi upgraded Dr. Reddy's Laboratories to buy from sell, raising target price to Rs 1450
29 Sep 2026
Dr Reddy's was among the top Nifty gainers after a double upgrade from Citi
29 Sep 2026
Dr Reddy was among the top gainers on the Nifty after a double upgrade from Citi
29 Sep 2026
Source: Live TV News Channel · 29 Sep 2026
The call above is Citi's, reported here as they made it. Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.